<DOC>
	<DOC>NCT02665377</DOC>
	<brief_summary>Prospective, blinded, placebo-controlled trial. Patients: Adult patients (&gt;18 years of age) undergoing de novo Htx, with a preoperative GFR &gt; 60ml/min, not receiving an ABO-incompatible organ with an ischemia time of &gt; 6 hours. A donor age &gt; 70 years is an exclusion criterion together with a severe intraoperative graft dysfunction causing intra-operative death or need for mechanical cardiac support. Intervention: Infusion of h-ANP fore five days, starting at the induction of anesthesia. Outcome: Kidney function, evaluated with serum creatinine and kidney clearance, 4-5 Days after Htx plus after 3 and 12 months.</brief_summary>
	<brief_title>Prevention of Akute Kidney Injury, Hearttransplant, ANP</brief_title>
	<detailed_description />
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>De novo Htx. Preoperative GFR &gt; 40ml/min/1,73m2. &gt;18 years old. Written consent. Multi organ transplantation or previous heart transplant. Donor age &gt; 70 years. Dialysis. Severe intraoperative graft dysfunction causing intraoperative death or the need for mechanical support. ABOincompatible organ. Ischemia time &gt; 6 tim. Known kidney disease. Other planed study within 2 mounth.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>